Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting

References

• Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., … Partners PrEP Study Team. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367, 399–410. doi:10.1056/NEJMoa1108524
   PubMed Web of Science ®Google Scholar
• Baillargeon, J., Giordano, T. P., Rich, J. D., Wu, Z. H., Wells, K., Pollock, B. H., & Paar, D. P. (2009). Accessing antiretroviral therapy following release from prison. Journal of the American Medical Association, 301, 848–857. doi:10.1001/jama.2009.202
   PubMed Web of Science ®Google Scholar
• Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., … Moss, A. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366. doi:10.1097/00002030-200003100-00008
   PubMed Web of Science ®Google Scholar
• Barash, E. T., Hanson, D. L., Buskin, S. E., & Teshale, E. (2007). HIV-infected injection drug users: Health care utilization and morbidity. Journal of Health Care for the Poor and Underserved, 18, 675–686. doi:10.1353/hpu.2007.0053
   PubMed Web of Science ®Google Scholar
• Beck, E. J., Mandalia, S., Williams, I., Power, A., Newson, R., Molesworth, A., … Tang, A. (1999). Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of anti-retroviral therapy 1996–1997. National prospective monitoring system steering group. AIDS (London, England), 13, 2157–2164. doi:10.1097/00002030-199910220-00020
   PubMed Web of Science ®Google Scholar
• Caplehorn, J. R. M., Bell, J., Kleinbaum, D. G., & Gebski, V. J. (1993). Methadone dose and heroin use during maintenance treatment. Addiction, 88(1), 119–124. doi:10.1111/j.1360-0443.1993.tb02769.x
   PubMed Web of Science ®Google Scholar
• Chen, N. E., Meyer, J. P., Avery, A. K., Draine, J., Flanigan, T. P., Lincoln, T., & Altice, F. L. (2011). Adherence to HIV treatment and care among previously homeless jail detainees. AIDS and Behavior, 17, 2654–2666. doi:10.1007/s10461-011-0080-2
   Web of Science ®Google Scholar
• Donnell, D., Baeten, J. M., Kiarie, J., Thomas, K. K., Stevens, W., Cohen, C. R., … Celum, C. (2010). Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. The Lancet, 375, 2092–2098. doi:10.1016/S0140-6736(10)60705-2
   PubMed Web of Science ®Google Scholar
• Fazel, S., & Baillargeon, J. (2011). The health of prisoners. Lancet, 377, 956–965. doi:10.1016/S0140-6736(10)61053-7
   PubMed Web of Science ®Google Scholar
• Flanigan, T. P., & Beckwith, C. G. (2011). The intertwined epidemics of HIV infection, incarceration, and substance abuse: A call to action. The Journal of Infectious Diseases, 203, 1201–1203. doi:10.1093/infdis/jir034
   PubMed Web of Science ®Google Scholar
• Grossberg, R., Zhang, Y., & Gross, R. (2004). A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. Journal of Clinical Epidemiology, 57, 1107–1110. doi:10.1016/j.jclinepi.2004.04.002
   PubMed Web of Science ®Google Scholar
• He, N., Duan, S., Ding, Y., Rou, K., McGoogan, J. M., Jia, M., … Graham, S. M. (2013). Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One, 8, e77981. doi:10.1371/journal.pone.0077981.t005
   Google Scholar
• Joseph, H., Stancliff, S., & Langrod, J. (2000). Methadone maintenance treatment (MMT): A review of historical and clinical issues. The Mount Sinai Journal of Medicine, New York, 67, 347–364.
   PubMed Web of Science ®Google Scholar
• Jürgens, R., Nowak, M., & Day, M. (2011). HIV and incarceration: Prisons and detention. Journal of the International AIDS Society, 14(1), 26. doi:10.1186/1758-2652-14-26
   PubMedGoogle Scholar
• Kidder, D. P., Wolitski, R. J., Campsmith, M. L., & Nakamura, G. V. (2007). Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. American Journal of Public Health, 97, 2238–2245. doi:10.2105/AJPH.2006.090209
   PubMed Web of Science ®Google Scholar
• Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., & Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis. Lancet, 357, 1397–1401. doi:10.1016/S0140-6736(00)04562-1
   PubMed Web of Science ®Google Scholar
• Krusi, A., Wood, E., Montaner, J., & Kerr, T. (2010). Social and structural determinants of HAART access and adherence among injection drug users. The International Journal on Drug Policy, 21(1), 4–9. doi:10.1016/j.drugpo.2009.08.003
   PubMed Web of Science ®Google Scholar
• Kurtz, S. P., Surratt, H. L., Kiley, M. C., & Inciardi, J. A. (2005). Barriers to health and social services for street-based sex workers. Journal of Health Care for the Poor and Underserved, 16, 345–361. doi:10.1353/hpu.2005.0038
   PubMed Web of Science ®Google Scholar
• Kushel, M. B., Colfax, G., Ragland, K., Heineman, A., Palacio, H., & Bangsberg, D. R. (2006). Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. Clinical Infectious Diseases, 43, 234–242. doi:10.1086/505212
   PubMed Web of Science ®Google Scholar
• Ledergerber, B., Egger, M., Opravil, M., Telenti, A., Hirschel, B., Battegay, M., … Weber, R. (1999). Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study. Swiss HIV Cohort Study. Lancet, 353, 863–868.
   PubMed Web of Science ®Google Scholar
• Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS, 16, 767–774. doi:10.1097/00002030-200203290-00012
   PubMed Web of Science ®Google Scholar
• Lucas, G. M., Griswold, M., Gebo, K. A., Keruly, J., Chaisson, R. E., & Moore, R. D. (2006). Illicit drug use and HIV-1 disease progression: A longitudinal study in the era of highly active antiretroviral therapy. American Journal of Epidemiology, 163, 412–420. doi:10.1093/aje/kwj059
   PubMed Web of Science ®Google Scholar
• Malta, M., Magnanini, M. M. F., Strathdee, S. A., Bastos, F. I. (2010). Adherence to antiretroviral therapy among HIV-infected drug users: A meta-analysis. AIDS and Behavior, 14, 731–747. doi:10.1007/s10461-008-9489-7
   PubMed Web of Science ®Google Scholar
• Malta, M., Strathdee, S. A., Magnanini, M. M. F., & Bastos, F. I. (2008). Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction, 103, 1242–1257. doi:10.1111/j.1360-0443.2008.02269.x
   PubMed Web of Science ®Google Scholar
• McGowan, J. P., & Shah, S. S. (2000). Prevention of perinatal HIV transmission during pregnancy. Journal of Antimicrobial Chemotherapy, 46, 657–668. doi:10.1093/jac/46.5.657
   PubMed Web of Science ®Google Scholar
• Miller, C. L., Spittal, P. M., Laliberte, N., Li, K., Tyndall, M. W., O'shaughnessy, M. V., & Schechter, M. T. (2002). Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. Journal of Acquired Immune Deficiency Syndromes, 30, 335–351.
   PubMed Web of Science ®Google Scholar
• Milloy, M. J., Kerr, T., Buxton, J., Rhodes, T., Guillemi, S., Hogg, R., … Wood, E. (2011). Dose-response effect of incarceration events on Nonadherence to HIV antiretroviral therapy among injection drug users. Journal of Infectious Diseases, 203, 1215–1221. doi:10.1093/infdis/jir032
   PubMed Web of Science ®Google Scholar
• Milloy, M.-J. S., Marshall, B. D. L., Kerr, T., Buxton, J., Rhodes, T., Montaner, J., & Wood, E. (2012). Social and structural factors associated with HIV disease progression among illicit drug users: A systematic review. AIDS, 26, 1049–1063. doi:10.1097/QAD.0b013e32835221cc
   PubMed Web of Science ®Google Scholar
• Moss, A. R., Hahn, J. A., Perry, S., Charlebois, E. D., Guzman, D., Clark, R. A., & Bangsberg, D. R. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Diseases, 39, 1190–1198. doi:10.1086/424008
   PubMed Web of Science ®Google Scholar
• Murphy, E. L., Collier, A. C., Kalish, L. A., Assmann, S. F., Para, M. F., Flanigan, T. P., … Viral Activation Transfusion Study Investigators. (2001). Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Annals of Internal Medicine, 135(1), 17–26. doi:10.7326/0003-4819-135-1-200107030-00005
   PubMed Web of Science ®Google Scholar
• Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Holmberg, S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. New England Journal of Medicine, 338, 853–860. doi:10.1056/NEJM199803263381301
   PubMed Web of Science ®Google Scholar
• Palepu, A., Milloy, M.-J., Kerr, T., Zhang, R., & Wood, E. (2011). Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users. Journal of Urban Health, 88, 545–555. doi:10.1007/s11524-011-9562-9
   PubMed Web of Science ®Google Scholar
• Palepu, A., Tyndall, M. W., Joy, R., Kerr, T., Wood, E., Press, N., & Montaner, J. S. G. (2006). Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy. Drug and Alcohol Dependence, 84, 188–194. doi:10.1016/j.drugalcdep.2006.02.003
   PubMed Web of Science ®Google Scholar
• Panos, G., Samonis, G., Alexiou, V. G., Kavarnou, G. A., Charatsis, G., & Falagas, M. E. (2008). Mortality and morbidity of HIV infected patients receiving HAART: A cohort study. Current HIV Research, 6, 257–260.
   PubMed Web of Science ®Google Scholar
• Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., … Gray R. H. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai project study group. The New England Journal of Medicine, 342, 921–929. doi:10.1056/NEJM200003303421303
   PubMed Web of Science ®Google Scholar
• Rekart, M. L. (2005). Sex-work harm reduction. Lancet, 366, 2123–2134. doi:10.1016/S0140-6736(05)67732-X
   PubMed Web of Science ®Google Scholar
• Small, W., Wood, E., Betteridge, G., Montaner, J., & Kerr, T. (2009). The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: A qualitative study. AIDS Care, 21, 708–714. doi:10.1080/09540120802511869
   PubMed Web of Science ®Google Scholar
• Spittal, P. M., Bruneau, J., Craib, K. J. P., Miller, C., Lamothe, F., Weber, A. E., … Schechter, M. T. (2003). Surviving the sex trade: A comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care, 15, 187–195. doi:10.1080/0954012031000068335
   PubMed Web of Science ®Google Scholar
• Strathdee, S., Palepu, A., Cornelisse, P. G., Yip, B., O'shaughnessy, M. V., Montaner, J. S., … Hogg, R. S. (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 547–549.
   PubMed Web of Science ®Google Scholar
• Strathdee, S., Patrick, D. M., Currie, S. L., Cornelisse, P. G., Rekart, M. L., Montaner, J. S., & O’Shaughnessy, M. V. (1997). Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS, 11(8), F59–F65.
   PubMed Web of Science ®Google Scholar
• Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., … Volberding, P. A. (2012). Antiretroviral treatment of adult HIV infection: 2012 recommendations of the international antiviral society-USA panel. Journal of the American Medical Association, 308, 387–402. doi:10.1001/jama.2012.7961
   PubMed Web of Science ®Google Scholar
• Tyndall, M. W., Currie S., Spittal P., Li, K., Wood, E., O'shaughnessy, M. V., … Schechter, M. T. (2003). Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17, 887–893. doi:10.1097/00002030-200304110-00014
   PubMed Web of Science ®Google Scholar
• Uhlmann, S., Milloy, M.-J., Kerr, T., Zhang, R., Guillemi, S., Marsh, D., … Wood, E. (2010). Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction, 105, 907–913. doi:10.1111/j.1360-0443.2010.02905.x
   PubMed Web of Science ®Google Scholar
• Vanwesenbeeck, I. (2001). Another decade of social scientific work on sex work: A review of research 1990–2000. Annual Review of Sex Research, 12, 242–289.
   PubMedGoogle Scholar
• Wolfe, D., Carrieri, M. P., & Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. The Lancet, 376, 355–366. doi:10.1016/S0140-6736(10)60832-X
   PubMed Web of Science ®Google Scholar
• Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'shaughnessy, M. V., & Montaner, J. S. G. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139, 810–816.
   PubMed Web of Science ®Google Scholar
• Wood, E., Kerr, T., Tyndall, M. W., & Montaner, J. S. G. (2008). A review of barriers and facilitators of HIV treatment among injection drug users. AIDS, 22, 1247–1256. doi:10.1097/QAD.0b013e3282fbd1ed
   PubMed Web of Science ®Google Scholar
• Wood, E., Montaner, J. S. G., Yip, B., Tyndall, M. W., Schechter, M. T., O'shaughnessy, M. V., & Hogg, R. S. (2003). Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users Journal De l’Association Medicale Canadienne [Canadian Medical Association Journal], 169, 656–661.
   PubMed Web of Science ®Google Scholar
• Wood, E., Montaner, J. S. G., Yip, B., Tyndall, M. W., Schechter, M. T., O'shaughnessy, M. V., & Hogg, R. S. (2004). Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users. Antiviral Therapy, 9, 229–235.
   PubMed Web of Science ®Google Scholar